• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期限制 2 型糖尿病老年患者晚期糖基化终产物(AGEs)的摄入是可行且有效的——一项先导性 RCT 的结果。

Long Term Dietary Restriction of Advanced Glycation End-Products (AGEs) in Older Adults with Type 2 Diabetes Is Feasible and Efficacious-Results from a Pilot RCT.

机构信息

The Nutrition and Brain Health Laboratory, The Institute of Biochemistry, Food and Nutrition Science, The Robert H. Smith Faculty of Agriculture Food and the Environment, The Hebrew University of Jerusalem, 7610001 Rehovot, Israel.

The Joseph Sagol Neuroscience Center, Sheba Medical Center, 5265601 Tel Hashomer, Israel.

出版信息

Nutrients. 2020 Oct 15;12(10):3143. doi: 10.3390/nu12103143.

DOI:10.3390/nu12103143
PMID:33076217
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7602440/
Abstract

INTRODUCTION

High serum concentrations of advanced glycation end-products (AGEs) in older adults and diabetics are associated with an increased risk of cognitive impairment. The aim of this pilot study was to assess the feasibility of long-term adherence to a dietary intervention designed to decrease intake and exposure to circulating AGEs among older adults with type 2 diabetes.

METHODS

Herein, 75 participants were randomized to either a standard of care (SOC) control arm or to an intervention arm receiving instruction on reducing dietary AGEs intake. The primary outcome was a change in serum AGEs at the end of the intervention. Secondary and exploratory outcomes included adherence to diet and its association with circulating AGEs. Cognitive function and brain imaging were also assessed but were out of the scope of this article (ClinicalTrials.gov Identifier: NCT02739971).

RESULTS

The intervention resulted in a significant change over time in several serum AGEs compared to the SOC guidelines. Very high adherence (above 80%) to the AGE-lowering diet was associated with a greater reduction in serum AGEs levels. There were no significant differences between the two arms in any other metabolic markers.

CONCLUSIONS

A long-term dietary intervention to reduce circulating AGEs is feasible in older adults with type 2 diabetes, especially in those who are highly adherent to the AGE-lowering diet.

摘要

简介

老年人和糖尿病患者血清中晚期糖基化终产物(AGEs)浓度升高与认知障碍风险增加有关。本研究旨在评估通过饮食干预降低 2 型糖尿病老年患者体内循环 AGEs 摄入量和暴露量的长期依从性的可行性。

方法

75 名参与者被随机分配到标准护理(SOC)对照组或接受减少饮食 AGEs 摄入量指导的干预组。主要结局是干预结束时血清 AGEs 的变化。次要和探索性结局包括饮食的依从性及其与循环 AGEs 的关系。认知功能和脑成像也进行了评估,但不在本文范围内(临床试验标识符:NCT02739971)。

结果

与 SOC 指南相比,干预后几种血清 AGEs 随时间发生显著变化。非常高的(高于 80%)对降低 AGE 饮食的依从性与血清 AGEs 水平的更大降低相关。两组之间在任何其他代谢标志物方面均无显著差异。

结论

降低循环 AGEs 的长期饮食干预在 2 型糖尿病老年患者中是可行的,尤其是在高度依从降低 AGE 饮食的患者中。

相似文献

1
Long Term Dietary Restriction of Advanced Glycation End-Products (AGEs) in Older Adults with Type 2 Diabetes Is Feasible and Efficacious-Results from a Pilot RCT.长期限制 2 型糖尿病老年患者晚期糖基化终产物(AGEs)的摄入是可行且有效的——一项先导性 RCT 的结果。
Nutrients. 2020 Oct 15;12(10):3143. doi: 10.3390/nu12103143.
2
Effect of Advanced Glycation End Products on Cognition in Older Adults with Type 2 Diabetes: Results from a Pilot Clinical Trial.晚期糖基化终产物对 2 型糖尿病老年患者认知功能的影响:一项初步临床试验结果。
J Alzheimers Dis. 2021;82(4):1785-1795. doi: 10.3233/JAD-210131.
3
Design and Feasibility of a Randomized Controlled Pilot Trial to Reduce Exposure and Cognitive Risk Associated With Advanced Glycation End Products in Older Adults With Type 2 Diabetes.一项随机对照试验的设计与可行性研究,旨在降低2型糖尿病老年患者中晚期糖基化终末产物相关暴露及认知风险
Front Nutr. 2021 Feb 15;8:614149. doi: 10.3389/fnut.2021.614149. eCollection 2021.
4
Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.在一项随机对照试验中,健康成年人的晚期糖基化终产物饮食摄入量并未影响内皮功能和炎症。
J Nutr. 2014 Jul;144(7):1037-42. doi: 10.3945/jn.113.189480. Epub 2014 Apr 17.
5
Increased calcium intake from skimmed milk in energy-restricted diets reduces glycation markers in adults with type 2 diabetes and overweight: A secondary analysis of a randomized clinical trial.限制能量摄入的饮食中增加脱脂牛奶的钙摄入量可降低 2 型糖尿病合并超重成人的糖基化标志物:一项随机临床试验的二次分析。
Nutr Res. 2024 Jul;127:40-52. doi: 10.1016/j.nutres.2024.04.008. Epub 2024 May 2.
6
Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial.晚期糖基化终产物饮食限制对腹膜透析患者肠道细菌微生物群的影响;一项随机开放标签对照试验。
PLoS One. 2017 Sep 20;12(9):e0184789. doi: 10.1371/journal.pone.0184789. eCollection 2017.
7
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes.在2型糖尿病患者中,膳食晚期糖基化终产物的高摄入量与动脉僵硬度增加和炎症相关。
Nutr Metab Cardiovasc Dis. 2017 Nov;27(11):978-984. doi: 10.1016/j.numecd.2017.06.014. Epub 2017 Jul 8.
8
Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.饮食中晚期糖基化终产物的摄入量与血浆和尿液中晚期糖基化终产物水平升高有关:CODAM 研究。
Clin Nutr. 2018 Jun;37(3):919-925. doi: 10.1016/j.clnu.2017.03.019. Epub 2017 Mar 23.
9
Correlation between serum advanced glycation end products and dietary intake of advanced glycation end products estimated from home cooking and food frequency questionnaires.血清晚期糖基化终产物与家庭烹饪和食物频率问卷估计的饮食摄入晚期糖基化终产物的相关性。
Nutr Metab Cardiovasc Dis. 2023 Sep;33(9):1768-1777. doi: 10.1016/j.numecd.2023.05.022. Epub 2023 May 24.
10
Dietary Advanced Glycation End Products and Cardiometabolic Risk.膳食晚期糖基化终产物与心血管代谢风险。
Curr Diab Rep. 2017 Aug;17(8):63. doi: 10.1007/s11892-017-0891-2.

引用本文的文献

1
Meloxicam mitigated methylglyoxal-induced glycative stress in rats.美洛昔康减轻了甲基乙二醛诱导的大鼠糖基化应激。
Iran J Basic Med Sci. 2025;28(5):647-654. doi: 10.22038/ijbms.2025.83856.18143.
2
Dietary Restriction of Advanced Glycation End-Products (AGEs) in Patients with Diabetes: A Systematic Review of Randomized Controlled Trials.糖尿病患者饮食中晚期糖基化终产物(AGEs)限制:一项随机对照试验的系统评价。
Int J Mol Sci. 2024 Oct 23;25(21):11407. doi: 10.3390/ijms252111407.
3
Phloroglucinol inhibited glycation via entrapping carbonyl intermediates.没食子丙醇通过捕获羰基中间产物来抑制糖基化。
PLoS One. 2024 Jul 25;19(7):e0307708. doi: 10.1371/journal.pone.0307708. eCollection 2024.
4
An Intensive Culinary Intervention Programme to Promote Healthy Ageing: The SUKALMENA-InAge Feasibility Pilot Study.一项促进健康老龄化的强化烹饪干预计划:SUKALMENA-InAge 可行性试点研究。
Nutrients. 2024 Jun 1;16(11):1735. doi: 10.3390/nu16111735.
5
The Role of Advanced Glycation End Products on Dyslipidemia.晚期糖基化终末产物在血脂异常中的作用。
Metabolites. 2023 Jan 3;13(1):77. doi: 10.3390/metabo13010077.
6
Receptor of advanced glycation end-products axis and gallbladder cancer: A forgotten connection that we should reconsider.晚期糖基化终产物受体轴与胆囊癌:一个被遗忘的联系,我们应该重新考虑。
World J Gastroenterol. 2022 Oct 21;28(39):5679-5690. doi: 10.3748/wjg.v28.i39.5679.
7
Accumulation of Advanced Glycation End-Products in the Body and Dietary Habits.体内晚期糖基化终产物的积累与饮食习惯。
Nutrients. 2022 Sep 25;14(19):3982. doi: 10.3390/nu14193982.
8
Design and Feasibility of a Randomized Controlled Pilot Trial to Reduce Exposure and Cognitive Risk Associated With Advanced Glycation End Products in Older Adults With Type 2 Diabetes.一项随机对照试验的设计与可行性研究,旨在降低2型糖尿病老年患者中晚期糖基化终末产物相关暴露及认知风险
Front Nutr. 2021 Feb 15;8:614149. doi: 10.3389/fnut.2021.614149. eCollection 2021.

本文引用的文献

1
CONSORT 2010 statement: extension to randomised pilot and feasibility trials.《CONSORT 2010声明:随机试点和可行性试验的扩展》
BMJ. 2016 Oct 24;355:i5239. doi: 10.1136/bmj.i5239.
2
Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes.晚期糖基化终末产物可预测肾功能丧失,并与2型糖尿病美国印第安人的糖尿病肾病病变相关。
Diabetes. 2016 Dec;65(12):3744-3753. doi: 10.2337/db16-0310. Epub 2016 Sep 8.
3
Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial.口服年龄限制改善代谢综合征肥胖个体的胰岛素抵抗:一项随机对照试验。
Diabetologia. 2016 Oct;59(10):2181-92. doi: 10.1007/s00125-016-4053-x. Epub 2016 Jul 29.
4
Effect of diet-derived advanced glycation end products on inflammation.饮食源性晚期糖基化终产物对炎症的影响。
Nutr Rev. 2015 Nov;73(11):737-59. doi: 10.1093/nutrit/nuv030. Epub 2015 Sep 15.
5
The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.晚期糖基化终产物在各类神经退行性疾病中的作用:一种治疗方法。
Cell Mol Biol Lett. 2014 Sep;19(3):407-37. doi: 10.2478/s11658-014-0205-5. Epub 2014 Aug 20.
6
Nutrition therapy recommendations for the management of adults with diabetes.成人糖尿病管理的营养治疗建议。
Diabetes Care. 2014 Jan;37 Suppl 1:S120-43. doi: 10.2337/dc14-S120.
7
Advanced glycation endproducts in food and their effects on health.食品中的晚期糖基化终产物及其对健康的影响。
Food Chem Toxicol. 2013 Oct;60:10-37. doi: 10.1016/j.fct.2013.06.052. Epub 2013 Jul 16.
8
Suppression of native defense mechanisms, SIRT1 and PPARγ, by dietary glycoxidants precedes disease in adult humans; relevance to lifestyle-engendered chronic diseases.饮食糖基化终产物抑制内源性防御机制、SIRT1 和 PPARγ,先于成人疾病发生;与生活方式引发的慢性疾病相关。
Amino Acids. 2014 Feb;46(2):301-9. doi: 10.1007/s00726-013-1502-4. Epub 2013 May 1.
9
Validation of the Hebrew version of the MoCA test as a screening instrument for the early detection of mild cognitive impairment in elderly individuals.验证 MoCA 测试的希伯来语版本作为老年人群轻度认知障碍早期检测的筛查工具的有效性。
J Geriatr Psychiatry Neurol. 2012 Sep;25(3):155-61. doi: 10.1177/0891988712457047.
10
Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1.晚期糖基化终产物的限制可改善 2 型糖尿病患者的胰岛素抵抗:AGER1 和 SIRT1 的潜在作用。
Diabetes Care. 2011 Jul;34(7):1610-6. doi: 10.2337/dc11-0091.